CDMO Documentation Ownership During Technology Transfer
Identifying symptoms of documentation ownership issues during the technology transfer process is critical to effective remediation. Indicators may include:Click to read the full article.
Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer
How to Build a Tech Transfer Scorecard for CMOs
Recognizing issues early in the tech transfer process is crucial. Certain signals may indicate potential gaps or problems that need to be addressed: Click to read the full article.
CMO Transfer of High Potency Products: Containment and Cleaning Risks
Identifying symptoms or signals on the manufacturing floor or in a laboratory setting is critical for early detection of containment and cleaning issues during CMO transfers. Some common indicators include:Click…
CDMO Tech Transfer for Emerging Markets: Regulatory Considerations
Identifying initial signs of potential failure is critical during CMOs and CDMOs tech transfer. Symptoms may manifest in various ways:Click to read the full article.
How to Close CMO Tech Transfer Actions Before Commercial Approval
The first signs that a tech transfer process is experiencing difficulties often manifest as discrepancies between batches produced by the CMO and the established specifications during development. These symptoms may…
CMO and CDMO Tech Transfer Best Practices for Pharma Sponsors
Identifying the symptoms of potential tech transfer failures is critical for timely intervention. Common signals that may indicate trouble during the transfer process include:Click to read the full article.
Process Robustness at Scale in Pharmaceutical Manufacturing
Manufacturing teams can encounter a range of symptoms indicating potential problems with process robustness at scale. Recognizing these signals early is vital in implementing timely interventions to avoid significant disruptions.Click…
Process Robustness at Scale in Pharmaceutical Manufacturing
Identifying failure signals on the manufacturing floor or in the laboratory is crucial for maintaining process robustness. Common symptoms may include:Click to read the full article.
Process Robustness at Scale in Pharmaceutical Manufacturing
Identifying symptoms related to process robustness at scale is the first critical step in maintaining compliance and operational efficiency. Common signals may include:Click to read the full article.
How to Prove Process Robustness Before Commercial PPQ
Recognizing the early symptoms or signals indicative of potential process problems is crucial. Monitoring these signs enables timely containment and mitigates the risk of larger failures in the future.Click to…
How to Prove Process Robustness Before Commercial PPQ
Proving Process Robustness Prior to Commercial Process Performance Qualification Ensuring process robustness at scale is critical for any pharmaceutical manufacturing operation, particularly in pre-commercial stages. The lack of a demonstrated…
How to Prove Process Robustness Before Commercial PPQ
Identifying symptoms indicative of process variability or deficiencies is vital in pharmaceutical manufacturing. Signals on the shop floor or in laboratories can manifest as:Click to read the full article.